Condition
Rod Cone Dystrophy
Total Trials
4
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 1 (1)
Trial Status
Recruiting3
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07854899Not ApplicableNot Yet RecruitingPrimary
Natural History Study of Advanced RCD
NCT07807111Phase 1Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, and Efficacy of Gene Therapy (SPVN20) in Subjects With Rod-Cone Dystrophy
NCT07341763Not ApplicableRecruiting
Brain Stimulation Effects on Orientation and Mobility Skills in Adults With Vision Impairment
NCT05355415Recruiting
Adaptive Optics Imaging of Outer Retinal Diseases
Showing all 4 trials